1 |
A novel Kir2.6 mutation associated with hypokalemic periodic paralysis.Clin Neurophysiol. 2016 Jun;127(6):2503-8. doi: 10.1016/j.clinph.2016.03.008. Epub 2016 Mar 17.
|
2 |
Electromyographic Features in a Chinese Cohort With Hereditary Skeletal Muscle Channelopathies.J Clin Neurophysiol. 2020 May;37(3):231-238. doi: 10.1097/WNP.0000000000000635.
|
3 |
The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.
|
4 |
Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands.Neuromuscul Disord. 2018 May;28(5):402-407. doi: 10.1016/j.nmd.2018.03.006. Epub 2018 Mar 9.
|
5 |
Temperature-sensitive sodium channelopathy with heat-induced myotonia and cold-induced paralysis. Neurology. 2000 Jun 13;54(11):2179-81. doi: 10.1212/wnl.54.11.2179.
|
6 |
A novel sodium channel mutation in a family with hypokalemic periodic paralysis.Neurology. 1999 Dec 10;53(9):1932-6. doi: 10.1212/wnl.53.9.1932.
|
7 |
Phospholemman, a major regulator of skeletal muscle Na(+)/K(+)-ATPase, is not mutated in probands with hypokalemic periodic paralysis.Exp Ther Med. 2017 Oct;14(4):3229-3232. doi: 10.3892/etm.2017.4848. Epub 2017 Jul 28.
|
8 |
A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis.J Clin Endocrinol Metab. 2002 Nov;87(11):4881-4. doi: 10.1210/jc.2002-020698.
|
|
|
|
|
|
|